The Group's principal activity is to develop biopharmaceutical products and to conduct drug discovery activities with the focus on immunological and infectious diseases, cancer, and diseases on the central nervous system. The Group operates in Switzerland, USA and other countries.
Alacra Alerts:
Receive alerts on the latest reports on Cytos Biotechnology AG
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
